Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
-
Content Type
- Analyzed With
- Chemical Group
- Compounds
-
- Instrument
- Analysis Platform
-
Product
- Language
-
Language
Applied Filters
In this application note, the use of the AssayMAP Bravo platform is discussed for protein analysis of antibody drug conjugate Brentuximab Vedotin in monkey plasma, with particular attention to DAR workflow development.
- Publication Part Number: 5994-7084EN
- Created: 22 Feb 2024
- 2 MB
必威体育登录手机An SEC method identifying innovator and biosimilar insulin analog was developed using an Agilent AdvanceBio SEC 130Å, 7.8 × 300 mm, 2.7 μm column.
- Publication Part Number: 5991-6872EN
- Created: 12 May 2021
- 513 KB
Comparison of AdvanceBio SEC 200 Å 1.9 µm column for SEC analysis of hGH, hG-CSF and IFN alpha-2b therapeutic proteins with sub-2 µm particle columns from other vendors.
- Publication Part Number: 5994-1829EN
- Created: 30 Mar 2020
- 516 KB
必威体育登录手机Presents a method for the rapid analysis of a monoclonal antibody using the Agilent AdvanceBio SEC 200 Å 19 µm column.
- Publication Part Number: 5994-0828EN
- Created: 27 Mar 2020
- 414 KB
Comparison of HPLC method and a quick method developed using the Cary 60 UV-Vis
- Publication Part Number: 5991-7974EN
- Created: 13 Mar 2020
- 413 KB
This application note describes a robust LC/MS method for the analysis of native protein analysis.
- Publication Part Number: 5994-1739EN
- Created: 12 Mar 2020
- 948 KB
Improvements in resolution and shorter run times using AdvanceBio SEC 120 Å 1.9 μm, 4.6 x 300 mm column for insulin analysis.
- Publication Part Number: 5994-1566EN
- Created: 06 Feb 2020
- 319 KB
必威体育登录手机Agilent-NIST mAb application compendium
- Publication Part Number: 5994-1501EN
- Created: 01 Dec 2019
- 31 MB
必威体育登录手机Size Exclusion Chromatography Method Development of NIST mAb Using an Agilent AdvanceBio SEC 200 Å, 1.9 µm Column
- Publication Part Number: 5994-0876EN
- Created: 17 Apr 2019
- 809 KB
必威体育登录手机Describes a comparison between the Agilent AdvanceBio SEC 200 Å 1.9 µm column and other vendors' SEC columns in terms of mAb and ADC analysis.
- Publication Part Number: 5994-0827EN
- Created: 08 Apr 2019
- 756 KB
Size exclusion chromatography with light scattering detection was used to investigate the impact of varying SDS concentration on protein molecules.
- Publication Part Number: 5991-7989EN
- Created: 22 Nov 2017
- 1 MB
必威体育登录手机The Agilent AdvanceBio SEC column together with the Agilent 1260 Infinity II Bio-inert System is an ideal combination for the aggregate analysis of ADCs
- Publication Part Number: 5991-8244EN
- Created: 30 June 2017
- 752 KB
An aggregate analysis workflow for SEC mobile phase optimization and characterization of mAb aggregation profiles
- Publication Part Number: 5991-7476EN
- Created: 04 Nov 2016
- 544 KB
"This Application Note describes the quantification of aggregates in biotherapeutic
- Publication Part Number: 5991-7223EN
- Created: 01 Sep 2016
- 598 KB
必威体育登录手机Agilent AdvanceBioSEC columns used for fast, high resolution, sensitive, and reproducible separation and quantitation of mAbs and Antibody Drug Conjugate,
- Publication Part Number: 5991-7165EN
- Created: 01 Aug 2016
- 905 KB
Online 2D-LC characterization of monoclonal antibodies using SEC in the first dimension and IEX in the second dimension
- Publication Part Number: 5991-6906EN
- Created: 01 June 2016
- 7 MB
必威体育登录手机A SEC method for determining the purity of PEG Granulocyte Colony Stimulating Factor using an Agilent AdvanceBio SEC column with aqueous mobile phase.
- Publication Part Number: 5991-6791EN
- Created: 23 Mar 2016
- 331 KB
Shorter 150 mm AdvanceBio SEC columns and higher flow rates of 1.5 mL/min increase sample throughput by 400%, from 1.3 days to under 8 hours.
- Publication Part Number: 5991-6458EN
- Created: 11 Dec 2015
- 169 KB
Analysis of an mAb (trastuzumab) and an ADC (trastuzumab emtansine) by size exclusion chromatography with online mass spectrometry (SEC-MS)
- Publication Part Number: 5991-6439EN
- Created: 01 Dec 2015
- 953 KB
High resolution and sensitive size exclusion chromatography separates and quantitates rituximab aggregates/degradants in a bioinert LC with an AdvanceBio SEC column.
- Publication Part Number: 5991-6304EN
- Created: 16 Oct 2015
- 302 KB